Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KT-621 Long-Term Extension Study in Asthma
NCT07677059Phase 2Recruiting
- Sponsor
- Kymera Therapeutics
- Start
- Jun 2026
- Primary completion
- Dec 2028
- Countries
- 4
01
Overview
A Phase 2 trial of KT-621 in asthma, sponsored by Kymera Therapeutics. Started Jun 2026; status: recruiting.
02
Drugs
KT-621
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07677059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07677059.